Year of Award:
Molecular & Cellular Analysis Technologies
RUIZ, JOSEPH C
Other PI or Project Leader:
TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
The outcome of this SBIR application will be a rat model of colorectal cancer (CRC), which can be used to discover new targets for colon cancer therapy. CRC rats will be produced using Transposagen's novel technology for introducing somatic mutations in r